Interventions for Tuberculosis Control and Elimination 2002

215. Prazuck T, Fisch A, Simonnet F, Noat G. Lyell’s syndrome associated with
rifampicin therapy of tuberculosis in an AIDS patient. (Correspondence).
J Infect Dis 1990; 22: 629.
Scand
216. Kuaban C, Bercion R, Koulla-Shiro S. Current HIV seroprevalence rate and
incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving
thiacetazone-free antituberculosis treatment in Yaounde, Cameroon.
Afric J Med 1998; 44: 34-7.
Centr
217. Arora VK, Bedi RS, Arora R. Rifampicin induced menstrual disturbances. Ind
J Chest Dis All Sci 1987; 29: 63-4.
218. Wurtz RM, Abrams D, Becker S, Jacobson MA, Mass MM, Marks SH.
Anaphylactoid drug reactions to ciprofloxacin and rifampicin in HIV-infected
patients. (Correspondence). Lancet 1989; 1: 955-6.
219. Martínez E, Collazos J, Mayo J. Shock and cerebral infarct after rifampin reexposure
in a patient infected with human immunodeficiency virus.
Dis 1998; 27: 1329-30.
Clin Infect
220. Van Assendelft AHW. Leucopenia in rifampicin chemotherapy. J Antimicrob
Chemother 1985; 16: 407-8.
221. Conen D, Blumberg A, Weber S, Schubothe H. Hämolytische Krise und akutes
Nierenversagen unter Rifampicin. Schweiz Med Wochenschr 1979; 109: 558-62.
222. Kindelan JM, Serrano I, Jurado R, Villanueva JL, Garcia-Lazaro M, Garcia-
Herola A, Torre Cisneros J. Rifampin-induced severe thrombocytopenia in a
patient with pulmonary tuberculosis. (Correspondence).
28: 1304-5.
Ann Pharmacother 1994;
223. Bachs L, Parés A, Piera C, Elena M, Rodés J. Comparison of rifampicin with
phenobarbitone for treatment of pruritus in biliary cirrhosis. (Correspondence).
Lancet 1989; 1: 574-6.
224. Klaui H, Leuenberger P. Pseudomembranous colitis due to rifampicin.
(Correspondence). Lancet 1981; 2: 1294.
225. Nakajima A, Yajima S, Shirakura T, Ito T, Kataoka Y, Ueda K, Nagoshi D,
Kanemoto H, Matsubashi N. Rifampicin-associated pseudomembranous colitis.
J Gastroenterol 2000; 35: 299-303.
226. Lange P, Oun H, Fuller S, Turney JH. Eosinophilic colitis due to rifampicin.
(Correspondence). Lancet 1994; 344: 1296-7.
227. Berning SE, Iseman MD.
349: 1521-2.
Rifamycin-induced lupus syndrome. Lancet 1997;
228. Jenkins P, Emerson PA.
105-6.
Myopathy induced by rifampicin. BMJ 1981; 283:
229. Dutt AK, Moers D, Stead WW. Undesirable side effects of isoniazid and rifampin
in largely twice-weekly short-course chemotherapy for tuberculosis. Am Rev
Respir Dis 1983; 128: 419-24.
184